INTRODUCTION: Sexually transmitted infections (STIs) are managed syndromically in most developing countries. In Zimbabwe, men presenting with urethral discharge are treated with a single intramuscular dose of kanamycin or ceftriaxone in combination with a week's course of oral doxycycline. This study was designed to assess the current etiology of urethral discharge and other STIs to inform current syndromic management regimens. METHODS: We conducted a study among 200 men with urethral discharge presenting at 6 regionally diverse STI clinics in Zimbabwe. Urethral specimens were tested by multiplex polymerase chain reaction testing for Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis. In addition, serologic testing for syphilis and HIV was performed. RESULTS: Among the 200 studied men, one or more pathogens were identified in 163 (81.5%) men, including N. gonorrhoeae in 147 (73.5%), C. trachomatis in 45 (22.5%), T. vaginalis in 8 (4.0%), and M. genitalium in 7 (3.5%). Among all men, 121 (60%) had a single infection, 40 (20%) had dual infections, and 2 (1%) had 3 infections. Among the 45 men with C. trachomatis, 36 (80%) were coinfected with N. gonorrhoeae. Overall, 156 (78%) men had either N. gonorrhoeae or C. trachomatis identified. Of 151 men who consented to HIV testing, 43 (28.5%) tested positive. There were no differences in HIV status by study site or by urethral pathogen detected. CONCLUSIONS: Among men presenting at Zimbabwe STI clinics with urethral discharge, N. gonorrhoeae and C. trachomatis are the most commonly associated pathogens. Current syndromic management guidelines seem to be adequate for the treatment for symptomatic men, but future guidelines must be informed by ongoing monitoring of gonococcal resistance.
INTRODUCTION: Sexually transmitted infections (STIs) are managed syndromically in most developing countries. In Zimbabwe, men presenting with urethral discharge are treated with a single intramuscular dose of kanamycin or ceftriaxone in combination with a week's course of oral doxycycline. This study was designed to assess the current etiology of urethral discharge and other STIs to inform current syndromic management regimens. METHODS: We conducted a study among 200 men with urethral discharge presenting at 6 regionally diverse STI clinics in Zimbabwe. Urethral specimens were tested by multiplex polymerase chain reaction testing for Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis. In addition, serologic testing for syphilis and HIV was performed. RESULTS: Among the 200 studied men, one or more pathogens were identified in 163 (81.5%) men, including N. gonorrhoeae in 147 (73.5%), C. trachomatis in 45 (22.5%), T. vaginalis in 8 (4.0%), and M. genitalium in 7 (3.5%). Among all men, 121 (60%) had a single infection, 40 (20%) had dual infections, and 2 (1%) had 3 infections. Among the 45 men with C. trachomatis, 36 (80%) were coinfected with N. gonorrhoeae. Overall, 156 (78%) men had either N. gonorrhoeae or C. trachomatis identified. Of 151 men who consented to HIV testing, 43 (28.5%) tested positive. There were no differences in HIV status by study site or by urethral pathogen detected. CONCLUSIONS: Among men presenting at Zimbabwe STI clinics with urethral discharge, N. gonorrhoeae and C. trachomatis are the most commonly associated pathogens. Current syndromic management guidelines seem to be adequate for the treatment for symptomatic men, but future guidelines must be informed by ongoing monitoring of gonococcal resistance.
Authors: Z Mike Chirenje; Nicholas Dhibi; H Hunter Handsfield; Elizabeth Gonese; Beth Tippett Barr; Lovemore Gwanzura; Ahmed S Latif; Dumisili Venessa Maseko; Ranmini S Kularatne; Mufuta Tshimanga; Peter H Kilmarx; Anna Machiha; Owen Mugurungi; Cornelis A Rietmeijer Journal: Sex Transm Dis Date: 2018-06 Impact factor: 2.830
Authors: Cornelis A Rietmeijer; More Mungati; Peter H Kilmarx; Beth Tippett Barr; Elizabeth Gonese; Ranmini S Kularatne; David A Lewis; Jeffrey D Klausner; Luanne Rodgers; H Hunter Handsfield Journal: Sex Transm Dis Date: 2019-09 Impact factor: 2.830
Authors: Teodora Ec Wi; Francis J Ndowa; Cecilia Ferreyra; Cassandra Kelly-Cirino; Melanie M Taylor; Igor Toskin; James Kiarie; Nancy Santesso; Magnus Unemo Journal: J Int AIDS Soc Date: 2019-08 Impact factor: 5.396
Authors: Lucilene Sales de Souza; José Carlos Sardinha; Sinésio Talhari; Marcel Heibel; Mônica Nunes Dos Santos; Carolina Talhari Journal: An Bras Dermatol Date: 2021-01-31 Impact factor: 1.896
Authors: Matthew M Hamill; Annet Onzia; Tza-Huei Wang; Agnes N Kiragga; Yu-Hsiang Hsieh; Rosalind Parkes-Ratanshi; Ethan Gough; Peter Kyambadde; Johan H Melendez; Yukari C Manabe Journal: BMC Infect Dis Date: 2022-05-07 Impact factor: 3.667
Authors: Johan H Melendez; Justin Hardick; Annet Onzia; Tong Yu; Peter Kyambadde; Rosalind Parkes-Ratanshi; Edith Nakku-Joloba; Agnes Kiragga; Yukari C Manabe; Matthew M Hamill Journal: Microbiol Spectr Date: 2022-04-12
Authors: Avi J Hakim; Chelsea Iwamoto; Steven G Badman; Barne Willie; Simon Pekon; Herick Aeno; Ruthy Neo-Boli; Sophie Ase; Damian Weikum; Andrew J Vallely; Angela Kelly-Hanku Journal: Sex Transm Dis Date: 2021-02-01 Impact factor: 3.868
Authors: Meklit Workneh; Matthew M Hamill; Francis Kakooza; Emmanuel Mande; Jessica Wagner; Olive Mbabazi; Rodney Mugasha; Henry Kajumbula; Richard Walwema; Jonathan Zenilman; Patrick Musinguzi; Peter Kyambadde; Mohammed Lamorde; Yukari C Manabe Journal: JMIR Public Health Surveill Date: 2020-06-10
Authors: Kevin Martin; Ioana D Olaru; Nyasha Buwu; Tsitsi Bandason; Michael Marks; Ethel Dauya; Joice Muzangwa; David Mabey; Chido Dziva Chikwari; Suzanna C Francis; Mandikudza Tembo; Constancia Mavodza; Victoria Simms; Constance R S Mackworth-Young; Anna Machiha; Katharina Kranzer; Rashida A Ferrand Journal: Lancet Child Adolesc Health Date: 2021-01-06